Publicacións en colaboración con investigadores/as de Gustave Roussy Cancer Campus (2)

2024

  1. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532)

    European urology oncology, Vol. 7, Núm. 5, pp. 1051-1060

2012

  1. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomised, placebo-controlled trial

    The Lancet, Vol. 379, Núm. 9810, pp. 39-46